Extended adjuvant aromatase inhibition after sequential endocrine therapy (DATA): a randomised, phase 3 trialVivianne C. G. Tjan‐Heijnen, R. Vree, Petronella G.M. Peer et al.|The Lancet Oncology|2017Cited by 158